Function and regulatory mechanisms of the Wnt5a-Ror morphogenetic pathway
Wnt5a-Ror形态发生途径的功能和调控机制
基本信息
- 批准号:10558623
- 负责人:
- 金额:$ 43.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:ActomyosinAddressAutomobile DrivingBehaviorBehavioralBinding ProteinsBiochemicalBiological AssayBiological ProcessBiomechanicsCanis familiarisCell Culture SystemCell surfaceCellsCharacteristicsClinicalComplementComplexCongenital AbnormalityCongenital DisordersCytoplasmCytoskeletonCytosolDNA Sequence AlterationDefectDevelopmentDiseaseDsh proteinElementsExhibitsFaceGeneticGoalsHumanKnock-outLigandsLimb structureMeasurementMediatingMorphogenesisMutationPathogenesisPathogenicityPathway interactionsPhenotypePhysiologicalPortraitsProcessProteinsRegulationReporterResearchRobinow syndromeRoleScaffolding ProteinSignal PathwaySignal TransductionStress FibersStructureTissuesTransducersVertebratesWNT5A genecell behaviorcell motilityexperimental studyhuman diseaseinsightinterestnovelpharmacologicreceptorthree dimensional cell culturetransmission process
项目摘要
Project Summary/Abstract
Wnt5a-Ror signaling is an evolutionarily conserved developmental signaling pathway that controls
morphogenetic cell and tissue behavior. Misregulation of the pathway in vertebrates results in profound tissue
elongation defects, including shortening and widening of the body axis, limbs, and face. In humans, mutations
in key nodes of the pathway, including the WNT5A ligand, the ROR2 and Frizzled (FZD2) co-receptors, and the
cytoplasmic signal transducers Dishevelled (DVL) 1 and DVL3, give rise to Robinow syndrome, a congenital
disorder with highly similar tissue elongation phenotypes. Notably, bulldogs exhibit similar physical
characteristics and carry a mutation in DVL2, analogous to the human mutations in DVL1 and DVL3, that reduces
its capacity to respond to Wnt5a-Ror signals. Despite its physiological and clinical importance, the biochemical
steps and cytoskeletal mechanisms that mediate Wnt5a-Ror signaling remain largely uncharacterized;
consequently, insights into the disease mechanism(s) driving Robinow syndrome are unknown. The overarching
goal of our research is to dissect Wnt5a-Ror pathway function and regulation at the biochemical, cellular and
organismal levels. Specifically, we ask in this proposal: 1) How does the Ror/FZD co-receptor complex transmit
Wnt5a signals at the cell surface, and how do pathogenic mutations in ROR2 alter receptor complex function?
2) How do Dvl scaffolding proteins relay Wnt5a-Ror signals in the cytosol, and how do mutations in human DVL1
and DVL3 and canine DVL2 disrupt DVL function? 3) How does the Wnt5a-Ror pathway engage the cytoskeleton
to alter cell behavior and biomechanics, and how do disease mutations in the pathway perturb these processes?
To address these questions, we have developed novel reporter assays that enable quantitative measurement of
Wnt5a-Ror signaling activity in live cells. We have also developed a highly physiological cell culture system in
which we can readily knock out and re-express proteins of interest at near-endogenous levels to rescue signaling.
Using this approach, we will conduct detailed ROR2 and DVL structure-function analyses to identify the structural
elements and mechanisms required for these proteins’ respective functions. These experiments will be
complemented by protein binding studies to define ROR2 and DVL protein interaction networks and how their
disruption contributes to disease pathogenesis. To elucidate the cell biological function of the pathway, we have
optimized 2D and 3D culture systems for cell behavioral analyses and identified a critical role for Wnt5a-Ror
signaling in controlling cell migration, stress fiber stabilization and actomyosin-based contractility. These
observations coincide with biochemical and subcellular localization changes in the RhoA-MLC-actomyosin
regulatory network. We will conduct pharmacological and genetic perturbation experiments to dissect the
function of this network in normal and pathogenic Wnt5a-Ror-directed cell behaviors. The successful completion
of this project will yield the first detailed mechanistic portrait of the Wnt5a-Ror signaling network and illuminate
the pathogenic mechanisms of Wnt5a-Ror-driven diseases.
项目总结/摘要
Wnt 5a-Ror信号传导是一种进化上保守的发育信号传导途径,
形态发生细胞和组织行为。在脊椎动物中,该途径的失调导致深层组织
伸长缺陷,包括体轴、四肢和面部的缩短和加宽。在人类中,
在途径的关键节点,包括WNT 5A配体,ROR 2和Frizzled(FZD 2)共受体,以及
细胞质信号转导紊乱(DVL)1和DVL 3,引起Robinow综合征,一种先天性
具有高度相似的组织伸长表型的疾病。值得注意的是,斗牛犬表现出类似的身体
在DVL 2中携带突变,类似于DVL 1和DVL 3中的人类突变,
其响应Wnt 5a-Ror信号的能力。尽管其在生理和临床上的重要性,
介导Wnt 5a-Ror信号传导的步骤和细胞骨架机制仍然在很大程度上未被表征;
因此,对驱动Robinow综合征的疾病机制的了解是未知的。总体
我们的研究目标是从生物化学、细胞学和免疫学角度剖析Wnt 5a-Ror通路的功能和调控,
有机体水平。具体来说,我们在这个建议中提出:1)Ror/FZD共受体复合物如何传递
Wnt 5a在细胞表面发出信号,ROR 2中的致病性突变如何改变受体复合物的功能?
2)Dvl支架蛋白如何在胞质溶胶中传递Wnt 5a-Ror信号,以及人DVL 1中的突变如何
DVL 3和犬DVL 2会破坏DVL功能?3)Wnt 5a-Ror通路如何参与细胞骨架
改变细胞行为和生物力学,以及疾病突变如何干扰这些过程?
为了解决这些问题,我们开发了新的报告基因测定,
活细胞中的Wnt 5a-Ror信号传导活性。我们还开发了一种高度生理化的细胞培养系统,
我们可以很容易地敲除并在接近内源性的水平上重新表达感兴趣的蛋白质以拯救信号传导。
使用这种方法,我们将进行详细的ROR 2和DVL结构功能分析,以确定结构
这些蛋白质各自功能所需的元件和机制。这些实验将
通过蛋白质结合研究来补充,以定义ROR 2和DVL蛋白质相互作用网络,以及它们如何相互作用。
破坏有助于疾病的发病机理。为了阐明该通路的细胞生物学功能,我们
优化了用于细胞行为分析的二维和三维培养系统,并确定了Wnt 5a-Ror的关键作用。
在控制细胞迁移、应力纤维稳定和基于肌动球蛋白的收缩性中的信号传导。这些
观察结果与RhoA-MLC-肌动球蛋白中的生化和亚细胞定位变化一致
监管网络。我们将进行药理学和遗传扰动实验,
该网络在正常和致病性Wnt 5a-Ror指导的细胞行为中的功能。圆满完成
该项目将产生Wnt 5a-Ror信令网络的第一个详细的机械图,并阐明
Wnt 5a-Ror驱动的疾病的致病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hsin-Yi Henry Ho其他文献
Hsin-Yi Henry Ho的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hsin-Yi Henry Ho', 18)}}的其他基金
Function and regulatory mechanisms of the Wnt5a-Ror morphogenetic pathway
Wnt5a-Ror形态发生途径的功能和调控机制
- 批准号:
10336968 - 财政年份:2022
- 资助金额:
$ 43.13万 - 项目类别:
Deciphering Wnt-Ror signaling in cytoskeletal regulation and tissue shape control
解读细胞骨架调节和组织形状控制中的 Wnt-Ror 信号传导
- 批准号:
10389593 - 财政年份:2016
- 资助金额:
$ 43.13万 - 项目类别:
Deciphering Wnt-Ror signaling in cytoskeletal regulation and tissue shape control
解读细胞骨架调节和组织形状控制中的 Wnt-Ror 信号传导
- 批准号:
9323512 - 财政年份:2016
- 资助金额:
$ 43.13万 - 项目类别:
Deciphering Wnt-Ror signaling in cytoskeletal regulation and tissue shape control
解读细胞骨架调节和组织形状控制中的 Wnt-Ror 信号传导
- 批准号:
9749980 - 财政年份:2016
- 资助金额:
$ 43.13万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 43.13万 - 项目类别:
Research Grant